The variation of results in cost-benefit analyses for particular treatments can be bewildering to medical experts unfamiliar with real-world healthcare financing. This article gives a basic background on cost-benefit analyses in healthcare, using lung cancer screening as a case study.

This article was originally published in the Annals of Translational Medicine.